Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1176-1181

  Kok, Petra ^a   Roelfsema, Ferdinand ^a   Frölich, Marijke ^a   Van Pelt, Johannes ^a   Meinders, A Edo ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; THYROTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HUMAN; MENSTRUAL CYCLE; NAUSEA; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; THYROTROPIN RELEASE; VOMITING;

EID: 65249133144     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2303     Document Type: Article

References (42)

1. Kok P, Roelfsema F, Frolich M, van Pelt J, Meinders AE, Pijl H 2008 Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women. J Clin Endocrinol Metab 93:3455-3461
2. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H 2004 Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab 89:4445-4449
3. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H 2005 Spontaneous diurnal thyrotropin secretion is enhanced in proportion to circulating leptin in obese premenopausal women. J Clin Endocrinol Metab 90:6185-6191
4. Mariotti S 2006 Normal physiology of the hypothalamo-pituitary- thyroidal system and relation to the neural system and other endocrine gland. Chap 4. Thyroid Disease Manager. www.thyroidmanager.org/Chapter4
5. Romijn JA, Adriaanse R, Brabant G, Prank K, Endert E, Wiersinga WM 1999 Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. J Clin Endocrinol Metab 70:1631-1636
6. Morley JE 1981 Neuroendocrine control of thyrotropin secretion. Endocr Rev 12:396-436
7. Lechan RM, Fekete C 2006 The TRH neuron: a hypothalamic integrator of energy metabolism. In: Kalsbeek A, Fliers E, Hofman M, Swaab DF, van Someren EJW, Buijs RM, eds. Progress in Brain Research 153:209-235. Amsterdam: Elsevier B.V.
8. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS 2001 Brain dopamine and obesity. Lancet 357:354-357
9. Rossmanith WG, Mortola JF, Laughlin GA, Yen SS 1988 Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women. J Clin Endocrinol Metab 67:560 -564
10. Seoane LM, Carro E, Tovar S, Casanueva FF, Dieguez C 2000 Regulation of in vivo TSH secretion by leptin. Regul Pept 92:25-29
11. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS 2003 The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short- term starvation in healthy men. J Clin Invest 111:1409 -1421
12. Mantzoros CS, Ozata M, Negrao AB, Suchard MA, Ziotopoulou M, Caglayan S, Elashoff RM, Cogswell RJ, Negro P, Liberty V, Wong ML, Veldhuis J, Ozdemir IC, Gold PW, Flier JS, Licinio J 2001 Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 86:3284-3291
13. KokP, Roelfsema F, FrolichM, vanPeltJ, Meinders AE, PijlH 2006 Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women. J Clin Endocrinol Metab 91:3236 -3240
14. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V 2002 Dopaminergic tone and obesity: an insight from prolacti- nomas treated with bromocriptine. Eur J Endocrinol 147:77-84
15. Mastronardi CA, Yu WH, Srivastava VK, Dees WL, McCann SM 2001 Li- popolysaccharide-induced leptin release is neuronal controlled. Proc Natl Acad Sci USA 98:14720-14725
16. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD 2003 Physiological control of pituitary hormone secretory-burst mass, frequency, and waveform: a statistical formulation and analysis. Am J Physiol Regul Integr Comp Physiol 285:R664 -R673
17. Veldhuis JD, Straume M, IranmaneshA, MulliganT, JaffeC, BarkanA, Johnson ML, Pincus S 2001 Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol Regul Integr Comp Physiol 280:R721-R729
18. Liu PY, Pincus SM, Keenan DM, Roelfsema F, Veldhuis JD 2005 Analysis of bidirectional pattern synchrony of concentration-secretion pairs: implementation in the human testicular and adrenal axes. Am J Physiol Regul Integr Comp Physiol 288:R440 -R446
19. Ohzeki T, Hanaki K, Motozumi H, Ohtahara H, Ishitani N, Urashima H, Tsukuda T, Shiraki K, Sasaki, Nakamura H 1993 Efficacy of bromocriptine administration for selective pituitaryresistance to thyroid hormone. Horm Res 39:229-234
20. Lewis BM, Dieguez C, Lewis MD, Scanlon MF 1987 Dopamine stimulates release of thyrotrophin-releasing hormone from perfused intact rat hypothal- amus via hypothalamic D2-receptors. J Endocrinol 115:419 -424
21. Samuels MH, Henry P, Ridgway EC 1992 Effects of dopamine and somatostatin in pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab 74:217-222
22. Brabant G, Prank K, Hoang-Vu C, Hesch RD, von zur Mühlen A 1991 Hy- pothalamic regulation of pulsatile thyrotropin secretion. J Clin Endocrinol Metab 72:145-150
23. Boesgaard S, Hagen C, Hangaard J, Andersen AN, Eldrup E 1990 Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women. Clin Endocrinol (Oxf) 32:423-431
24. Levinson PD, Goldstein DS, Munson PJ, GillJr JR, Keiser HG 1985 Endocrine, renal and hemodynamic responses to graded dopamine infusions in normal men. J Clin Endocrinol Metab 60:821-826
25. Ciccarrelli E, Touzel R, Besser M, Grossman A 1988 Terguride-a new do- pamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine. Fertil Steril 49:589 -594
26. Gaillard RC, Brownell J 1988 Hormonal effects of CV 205-502, a novel octahydrobenzo[g] quinoline with potent dopamine agonist properties. Life Sci 43:1355-1362
27. Krause W, Trämger H, Kühne G, Gräf K-J, Dorow R 1990 Pharmacokinetics and endocrine effects of terguride in healthy subjects. Eur J Clin Pharmacol 38: 609-615
28. Parker DC, Rossman IG, Pekary AE, Hersmann JM 1987 Effect of 64-hour sleep deprivation on the circadian waveform of thyrotropin (TSH): further evidence of sleep-related inhibition of TSH release. J Clin Endocrinol Metab 64:157-161
29. Kok P, Roelfsema F, Langendonk JG, Frolich M, Burggraaf J, Meinders AE, Pijl H 2005 High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 90:4659-4663
30. Visser TJ, Lamberts SW, Wilson JH, Docter R, Hennemann G 1978 Serum thyroid hormone concentrations during prolonged reduction of dietary intake. Metabolism 27:405-409
31. Magner JA 1990 Thyroid-stimulating hormone: biosynthesis, cell biology, and bioactivity. Endocr Rev 11:354 -385
32. Ahren B, Bengtsson HI, Hedner P 1986 Effects of norepinephrine on basal and thyrotropin-stimulated thyroid hormone secretion in the mouse. Endocrinology 119:1058 -1062
33. Melander A, Ericson LE, Ljunggren JG, Norberg KA, Persson B, Sundler F, Tibblin S, Westgren U 1974 Sympathetic innervation of the normal human thyroid. J Clin Endocrinol Metab 39:713-718
34. Carey RM, Van Loon GR, Baines AD, Kaiser DL 1983 Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocrip- tine in man. J Clin Endocrinol Metab 56:595-602
35. Pelletier G, Simard J 1991 Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus. Neurosci Lett 127:96 -98
36. Kok P, Roelfsema F, Frolich M, van Pelt J, Stokkel MP, Meinders AE, Pijl H 2006 Activation ofdopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab 291: E1038 -E1043
37. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P 1994 Body fat and sympathetic nerve activity in healthy subjects. Circulation 89:2634 - 2640
38. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G 1995 Sympathetic activation in obese normotensive subjects. Hypertension 25:560 -563
39. Pijl H 2003 Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome? Eur J Pharmacol 480:125-131
40. Davis TF, Marians R, LatifR 2002 The TSH receptor reveals itself. J Clin Invest 110:161-163
41. Valyasevi RW, Erickson DZ, Harteneck DA, Duttan CH, Heufelder AE, Jyonouchi SC, Bahn RS 1999 Differentiation of human orbital preadipocytes fibroblasts. J Clin Endocrinol Metab 84:2557-2562
42. Abe E, Marians RC, Yu W, Wu X-B, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M 2003 TSH is a negative regulator of skeletal remodeling. Cell 115:151-162